Chemring Group PLC

Chemring Group PLC Q4 2025 Earnings Recap

CMGMY Q4 2025 December 10, 2025

Chemring’s FY 2025 results reflect solid performance amidst U.K. government spending challenges, with a record order book supporting a strategic path to double revenues by 2030.

Market Reaction

1-Day -1.95%
5-Day -4.28%
30-Day +2.72%

Key Takeaways

  • Group revenue rose 2% to GBP 498 million, with operating margin improving from 14.3% to 14.8%.
  • Record order intake of GBP 781 million, up 20% year-on-year, contributing to a total order book of GBP 1.3 billion, a 32% increase.
  • Strong cash conversion at 114% and EPS growth of 3% against a backdrop of higher tax and finance costs.
  • Significant growth in the Countermeasures & Energetics segment, with operating profit up 37% and margins reaching 19.1%.
  • Continued investment in operational excellence underscores Chemring’s commitment to sustainable, long-term value creation amidst rising global defense spending.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit CMGMY on AllInvestView.

Get the Full Picture on CMGMY

Track Chemring Group PLC in your portfolio with real-time analytics, dividend tracking, and more.

View CMGMY Analysis